Business Description
Profusa Inc
NAICS : 423450
SIC : 3844
ISIN : US74319X1081
Description
Profusa Inc is a clinical-stage digital health and medical technology company. The Company's technology enables the development of bioengineered sensors that are designed to become one with the body to detect and continuously transmit actionable, clinical-grade data for personal and medical use. The Company's first offering in the European Union, the Lumee Oxygen Platform, is designed to report reliable tissue oxygen levels at various regions of interest, both acutely and long-term. The Lumee Oxygen Platform has been designed for use in applications where monitoring of compromised tissue is beneficial, such as peripheral artery disease that results in narrowing of blood vessels and reduced blood flow to the lower limbs; chronic wounds that do not heal properly; and reconstructive surgery.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.03 | |||||
Equity-to-Asset | -32.71 | |||||
Debt-to-Equity | -0.45 | |||||
Debt-to-EBITDA | -0.36 | |||||
Piotroski F-Score | N/A/9 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | -48.8 | |||||
3-Year EPS without NRI Growth Rate | -44.3 | |||||
3-Year FCF Growth Rate | -40.3 | |||||
3-Year Book Growth Rate | 54.7 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 21.02 | |||||
9-Day RSI | 24.81 | |||||
14-Day RSI | 26.77 | |||||
3-1 Month Momentum % | -63.27 | |||||
6-1 Month Momentum % | -96.69 | |||||
12-1 Month Momentum % | -99.69 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 0.02 | |||||
Quick Ratio | 0.02 | |||||
Cash Ratio | 0.01 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -42.3 | |||||
Shareholder Yield % | 3703.08 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
ROA % | -1505.25 | |||||
ROIC % | -138.46 | |||||
3-Year ROIIC % | 85.05 | |||||
ROC (Joel Greenblatt) % | -41880.24 | |||||
Moat Score | 4 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
EV-to-EBIT | -0.37 | |||||
EV-to-EBITDA | -0.37 | |||||
EV-to-FCF | -0.72 | |||||
Earnings Yield (Greenblatt) % | -270.27 | |||||
FCF Yield % | -1981.8 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:PFSA
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Profusa Inc Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -2006.327 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | - | ||
| 14-Day RSI | 26.77 | ||
| 14-Day ATR ($) | 0.665641 | ||
| 20-Day SMA ($) | 2.75275 | ||
| 12-1 Month Momentum % | -99.69 | ||
| 52-Week Range ($) | 1.69 - 4162.50026 | ||
| Shares Outstanding (Mil) | 0.53 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 9999 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Profusa Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Profusa Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| Third quarter earnings results for 2026 | 2026-11-19 | In 122 days | ||
| Second quarter earnings results for 2026 | 2026-08-14 | In 25 days | ||
| 0.04:1 Stock Split | 2026-07-07 | 2.85 (+22.32%) | ||
| General meeting for 2026 | 2026-06-23 10:00 | 4.06 (-1.55%) | ||
| First quarter earnings results for 2026 | 2026-05-15 | 10.74 (+0.30%) | ||
| Annual report for 2025 | 2026-04-15 | 17.37 (-2.03%) | ||
| 0.0133333:1 Stock Split | 2026-02-09 | 109.31 (+11.47%) | ||
| Third quarter earnings results for 2025 | 2025-11-19 | 336.94 (+4.36%) | ||
| Second quarter earnings results for 2025 | 2025-08-14 | 1,050.00 (+3.57%) | ||
| First quarter earnings results for 2025 | 2025-06-13 | -- |
Show
Entries
Profusa Inc Frequently Asked Questions
What is Profusa Inc(PFSA)'s stock price today?
The current price of PFSA is $1.74. The 52 week high of PFSA is $4162.50 and 52 week low is $1.69.
When is next earnings date of Profusa Inc(PFSA)?
The next earnings date of Profusa Inc(PFSA) is 2026-08-14 Est..
Does Profusa Inc(PFSA) pay dividends? If so, how much?
Profusa Inc(PFSA) does not pay dividend.
Guru Commentaries on NAS:PFSA
No articles.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Profusa Inc
Headlines
See More- 1
Jul 02, 2026
Profusa approves 1-for-25 reverse stock split; shares tumble
Seeking Alpha • 2:06pm
- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers